Arrowhead Pharmaceuticals, Inc. Common Stock (NASDAQ: ARWR) last traded at $60.73, down 3.22% on the session. The quote above updates while this page is open; the figures below are drawn from Arrowhead Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Arrowhead Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker ARWR. Its market capitalisation is $8.58 billion.
Valuation measures for Arrowhead Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $8.58B |
|---|---|
| Enterprise value | $10.17B |
| Price / sales | 12.81 |
| Price / book | 18.43 |
| Beta | 1.62 |
Trailing-twelve-month figures tagged in Arrowhead Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $669.50M |
|---|---|
| Net income (TTM) | -$322.64M |
| EPS (TTM) | -$2.18 |
| Operating margin | -33.82% |
| Return on equity | -69.31% |
| Cash | $54.76M |
Range and volume for ARWR over the past 52 weeks.
| 52-week high | $95.49 |
|---|---|
| 52-week low | $34.61 |
| Volume | 1.19M |
| Average volume | 1.89M |
| Previous close | $62.75 |
Invest a chosen dollar amount in Arrowhead Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ARWR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.